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ABSTRACT
Objective The assessment of potentially confounding
factors affecting colon microbiota composition is
essential to the identification of robust microbiome
based disease markers. Here, we investigate the link
between gut microbiota variation and stool consistency
using Bristol Stool Scale classification, which reflects
faecal water content and activity, and is considered a
proxy for intestinal colon transit time.
Design Through 16S rDNA Illumina profiling of faecal
samples of 53 healthy women, we evaluated
associations between microbiome richness,
Bacteroidetes:Firmicutes ratio, enterotypes, and genus
abundance with self-reported, Bristol Stool Scale-based
stool consistency. Each sample’s microbiota growth
potential was calculated to test whether transit time acts
as a selective force on gut bacterial growth rates.
Results Stool consistency strongly correlates with all
known major microbiome markers. It is negatively
correlated with species richness, positively associated to
the Bacteroidetes:Firmicutes ratio, and linked to
Akkermansia and Methanobrevibacter abundance.
Enterotypes are distinctly distributed over the BSS-scores.
Based on the correlations between microbiota growth
potential and stool consistency scores within both
enterotypes, we hypothesise that accelerated transit
contributes to colon ecosystem differentiation. While
shorter transit times can be linked to increased
abundance of fast growing species in Ruminococcaceae-
Bacteroides samples, hinting to a washout avoidance
strategy of faster replication, this trend is absent in
Prevotella-enterotyped individuals. Within this enterotype
adherence to host tissue therefore appears to be a more
likely bacterial strategy to cope with washout.
Conclusions The strength of the associations between
stool consistency and species richness, enterotypes and
community composition emphasises the crucial
importance of stool consistency assessment in gut
metagenome-wide association studies.
INTRODUCTION
Despite recent efforts undertaken to characterise
the healthy colon microbiota,1–4 many parameters
potentially affecting microbial composition and
metabolic capacity remain underexplored. The
identification of such confounding factors, includ-
ing diet,5 6 history of antibiotics intake,7 and
inflammation status,8 9 is essential to define the
boundaries of a healthy gut ecosystem and, hence,
to identify robust disease markers in clinical micro-
biome association studies.
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Significance of this study
What is already known on this subject?
▸ Stool consistency, measured by the Bristol Stool
Scale (BSS), reflects differences in water
content and activity in the colon ecosystem and
is correlated with colon transit time. (low
scores: firm stool and slow transit, high scores:
loose stool and fast transit).
▸ Species richness is proposed to be a major
marker for gut health because of the idea that
high bacterial richness and diversity often
reflect ecosystem stability and resilience
together with the consistent association
between disease and a reduction in the
number of species in a faecal sample.
▸ Faecal metagenomes have been shown to
stratify into enterotypes, splitting the human
population around three possible constellations
in terms of their gut microbial ecosystem;
likewise Firmicutes:Bacteroidetes and
Prevotellaceae:Bacteroidetes ratios have been
put forward as important stratifiers for gut
microbiomes.
What are the new findings?
▸ Observed species richness declines with higher
BSS scores reaching its minimum in individuals
with loose stool.
▸ Enterotypes are distinctly distributed over the
BSS scores: the Prevotella (P) enterotype is
more abundant in subjects with loose stool
while the Ruminococcaceae-Bacteroides (RB)
enterotype completely dominates the harder
stool samples.
▸ Within the RB enterotype, Methanobrevibacter
and Akkermansia are positively correlated with
colon transit time. A similar observation can be
made for Oxalobacter and Butyricimonas, while
Bacteroides is more abundant in loose stool.
▸ Microbiota growth potential is positively
correlated with BSS scores in the RB
enterotype, hinting to transit time as a
selective force on microbial life-strategies.
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Transit time is a key determinant of the gut microbial habitat,
affecting nutrient and water absorption along the intestine as
well as setting the pace of luminal microbial population clear-
ance during egestion.10 As direct measurement of transit time is
often impractical or mildly invasive, it has generally been
neglected in microbiome studies so far. However, stool consist-
ency as categorised by the Bristol Stool Scale (BSS) scores has
been put forward as a proxy for colonic transit rate,10–12 allow-
ing assessment of its impact even when applying home-based
sampling protocols. The use of the BSS is widespread in clinical
studies and has been advised for the assessment of constipation
and diarrhoea in functional bowel disorders.13–15 The BSS clas-
sifies human faeces into seven consistency categories, with
highest scores corresponding to loose stools and fast transit,
while lower scores stand for hard stools and longer colon transit
times.10–12 16 Each consistency category reflects differences in
moisture content of faecal material, with decreased water activ-
ity—associated with prolonged intestinal transit—limiting
microbial growth through reduced nutrient mobility and ham-
pered enzymatic activity.17 Hence, BSS categorisation sum-
marises the impact of two major—and obviously related—
selective forces shaping the gut ecosystem: rate of intestinal
transit and water activity.
Here, we used self-reported BSS scores combined with 16S
rDNA Illumina amplicon profiles of faecal samples of 53
healthy volunteers to assess potential associations between
microbiota composition and stool consistency. In a healthy
Western population, more than half of the stools passed are pre-
dicted to belong to the central BSS categories 3 and 4.11
However, increased occurrence of harder stools has been
reported to be more common among women.11 12 18 Hence, in
order to increase chances of sampling a more uniform distribu-




Fifty-three healthy women, aged 20–55 years (median 42.5),
were recruited as part of the Flemish Gut Flora Project. None
were diagnosed with cancer or IBD, or had taken diarrhoea
inhibitors, laxatives or prebiotics in the week before sampling,
nor antibiotics within 3 months before sampling (see online sup-
plementary table S1). The aims of the project and the commit-
ments required were explained by means of an information
brochure and all participants signed a statement of informed
consent. The participants’ general practitioner recorded their
medical history, together with height, weight, and waist and hip
circumferences. Volunteers recorded time of defaecation and
BSS and reported this information together with information
about general diet and health status in a questionnaire.
Characterisation of the bacterial component of the gut
microbiota by variable region 4 rDNA sequencing
Faecal samples were frozen at −20°C immediately after collec-
tion by the participants. After frozen transport to a collection
point in their neighbourhood and subsequent transport on dry
ice, samples were stored at −80°C within 72 h after delivery at
the collection point until DNA extraction. DNA extraction was
performed according to Godon et al.19 To amplify the variable
region 4 of the 16S rRNA gene, we used the 515F and 806R
primers (GTGCCAGCMGCCGCGGTAA and GGACTACHVG
GGTWTCTAAT, respectively) modified to contain Illumina
adapters and barcode sequences to allow for directional sequen-
cing. Amplifications were performed in triplicate as 25 μL reac-
tions containing 2 μL of diluted template (1:10), 2.5 μL of 10X
AccuPrime PCR Buffer I, 0.1 μL of AccuPrime Taq High
Fidelity (5 U/μL), and 0.5 μL of 515F and 1.0 μL of 806R
primer (10 μM of each primer). Thermal cycling consisted of an
initial denaturation step (3 min at 94°C), followed by 30 cycles
of denaturation (45 s at 94°C), annealing (60 s at 50°C) and
90 s extension at 72°C. Final extension consisted of 5 min at
72°C. Amplicons were quantified on the Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, California, USA)
and pooled in equimolar concentrations. Fragment size was
selected (∼400 bp) by cutting the main band from the agarose
gel to reduce non-specific products of amplification. A final
library size and quantification was also conducted with the
Agilent Bioanalyzer. Sequencing was performed on the Illumina
MiSeq platform (MiSeq Reagent Kit V.2, 500 cycles) according
to the manufacturer’s specifications to generate paired-end reads
of 250 bases in length in each direction. The overlapping
paired-end reads were merged using fastq-join20 and processed
with MacQIIME V.1.8. Only Illumina reads with a length
>250 bp and an average quality score above 30, were retained
for further analysis. Reads were assigned to operational taxo-
nomic units (OTUs) by de novo OTU picking through the
QIIME pipeline. This way 99.6%, 87.6%, 53.4% and 12.5% of
the reads were assigned to order, family, genus and species
levels, respectively. Closed OTU picking with QIIME against the
Greengenes 2013 database was performed in addition for a
more stringent taxonomic assignment. From OTU abundance
and their respective taxonomic classifications, feature abundance
matrices were calculated at different taxonomic levels, represent-
ing OTU and taxa abundance per sample. To compare the dif-
ferent samples, sample counts were rarefied to 26 260 reads for
the de novo OTU picking data set and 26 024 reads for closed
OTU picking and trimmed for the consequently absent OTUs
with the phyloseq package based on the minimum of the sum of
taxa abundances in RV.3.0.1.
Statistical analysis
Statistical analysis was conducted on the rarefied and trimmed
feature abundance matrices using RV.3.0.1. Clustering of the
samples into enterotypes was done using the cluster package21
according to instructions available on http://enterotyping.embl.
de. Optimal number of clusters was determined by the Calinski-
Harabasz index. In addition, enterotyping was performed
with Dirichlet multinomial mixtures (DMM) using the
DirichletMultinomial 1.6.0 package in R.22 Laplace was used to
determine the optimal number of clustering by penalising
model complexity. Clusters were assigned the enterotype
Ruminoccoccaceae-Bacteroides or Prevotella based on the taxa
Significance of this study
How might it impact on clinical practice in the
foreseeable future?
▸ Here we show that major alterations in species richness or
community composition could partially be reflecting variation
in stool consistency, hampering the identification, but
especially robustness and reproducibility of disease markers.
Proper confounder analysis is thus impossible without stool
consistency measurements. This study therefore stresses the
urgent necessity of these measurements in gut microbiota
research and clinical studies.
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dominating the enterotype as in the original article of
Arumugam et al23 (see online supplementary table S2).
Species richness (Observed, Chao1) and α diversity measure-
ments (Shannon) were calculated using the phyloseq package.24
Each sample’s microbiota growth potential was estimated as
the average of the maximum growth rates (maxGRs) of the
genera, weighted by their abundance in the sample. The maxGRs
of gut-reference species (IMG v4Ref) were estimated from
genomic traits25 and the median was assigned to the genus.
Correlations between species richness, microbiota growth
potential, and relative bacterial taxa abundance with BSS were
assessed by Spearman’s rank order correlation, as implemented
in R. p Values were corrected for multiple testing with
Benjamini-Hochberg false discovery rate correction (q value).
Spearman’s rank order correlation was used to check the correl-
ation between enterotype and transit time (BSS), based on the
percentage of each enterotype in each BSS category. Significance
of differences in microbiota growth potential between entero-
types was assessed by Wilcoxon signed rank test.
RESULTS
A healthy gut microbial ecosystem is generally thought to be
characterised by high bacterial richness and diversity, presumed
to reflect ecosystem stability and resilience.26 27 Faecal micro-
biome analyses have revealed a seemingly consistent association
between disease and a reduction in the observed or estimated
number of species in a sample, suggesting bacterial richness to
be a major marker for gut health.26 27 Here, we identify stool
consistency to be strongly associated to faecal microbial rich-
ness. Indeed, observed species’ richness significantly declines
with stool firmness (Spearman’s r=−0.45, p=0.0007), reaching
its minimum in diarrhoea-afflicted individuals (figure 1A).
Estimation of total species richness (Chao1) confirms this nega-
tive correlation (r=−0.41, p=0.003, data not shown) and the
signal remains significant with the application of a more strin-
gent taxonomical assignment (closed reference OTU picking,
see Methods; trend also confirmed in a data set excluding
patients with IBS, online supplementary figure S7, and in a data
set of 24 men, online supplementary figure S8). These results
are in line with anecdotal reports of decreased microbial rich-
ness associated with osmotic diarrhoea.28
Previously, faecal metagenomes have been shown to stratify
into enterotypes,23 splitting the human population around three
possible constellations in terms of their gut microbial commu-
nity structure. As enterotypes have also been linked to richness
gradients,8 9 we analysed the distribution of enterotypes over
stool consistency scores. Applying multiple clustering
approaches, we find that our current data set optimally separates
into two distinct clusters (see online supplementary table S2).
Named after the dominating taxa as in the reference publica-
tion,23 we refer to the clusters observed as the
Ruminococcaceae-Bacteroides (RB) and the Prevotella (P) enter-
otype (77% and 23% of total samples, respectively; partitioning
around medoids (PAM) clustering with Jensen-Shannon dis-
tance). The enterotypes observed are distinctly distributed over
BSS scores: while the P enterotype is more abundant in indivi-
duals with loose stools (r: 0.88, p=0.019), the RB enterotype
completely dominates firmer samples (r: −0.88, p=0.019;
figure 1B; trend also confirmed in men, online supplementary
figure S8). These observations are substantiated by the analysis
of the Firmicutes:Bacteroidetes and Prevotellaceae:Bacteroidetes
abundance ratios (both put forward as alternatives to enterotyp-
ing29) over stool score (respectively r=0.42, p=0.001 and r=
−0.04, p=0.77; see online supplementary figure S1A, B). Of
note, within the RB enterotype, Ruminococcaceae abundance
positively correlates with BSS scores (r=−0.37, p=0.016), while
Bacteroides populations increase in looser stools (r=0.43,
p=0.004) (see online supplementary figure S2). Hence, the
enhanced prevalence of the RB enterotype in the harder stool
categories is driven by the samples with a high
Ruminococcaceae:Bacteroides ratio, which would classify them
as Ruminococcaceae enterotype according to the terminology
originally suggested by Arumugam et al.23 As even within a
single enterotype low richness samples are more abundant in
looser stool (see online supplementary figure S3), the richness
signal is thus not a mere consequence of enterotype distribution
across consistency scores. Although the identification of environ-
mental factors shaping or contributing to enterotype stratifica-
tion is still ongoing, the potentially diverging impact of diet has
been emphasised previously.5 30 More specifically, the occur-
rence of the P enterotype has been linked to a rural, fibre-rich
diet.5 31 As non-fermentable fibre consumption is thought to
increase water content and plasticity of stool,32 this observation
fits with the increased prevalence of the P enterotype in the
loose stool categories. However, the question whether dietary
fibre consumption or the resulting changes in transit rate or
water activity are driving Prevotella blooms, remains currently
unanswered.
Stool consistency variation is associated with shifts in faecal
microbiota composition at the level of community structure and
Figure 1 Stool consistency variation
drives species richness and human
enterotypes. Correlation between
(A) observed species richness and stool
consistency, defined by Bristol Stool
Scale (BSS) (Spearman’s correlation,
r=−0.45, p=0.0007) and
(B) enterotype distribution and stool
consistency (BSS); Blue:
Ruminococcaceae-Bacteroides (RB)
enterotype (r=−0.88, p=0.019), green:
P enterotype (r=0.88, p=0.019).
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diversity, and it correlates with abundance gradients of individ-
ual genera (see online supplementary table S3). Within the RB
enterotype, Methanobrevibacter and Akkermansia populations
increase with stool firmness (and are thus more prevalent in
slow transit individuals). A similar observation can be made for
Oxalobacter and Butyricimonas, while Bacteroides is more abun-
dant in loose stools (see online supplementary figure S4). Most
of these associations remain significant in the total data set (see
table 1 and online supplementary figure S5) or when applying a
more stringent taxonomic assignment (see online supplementary
table S4).
The increased abundance of methanogens such as
Methanobrevibacter in harder stools confirms previous reports
of elevated methane production in constipated individuals.33 It
has been suggested that methane plays an active role in the
delay of transit by slowing down intestinal motility.34 Moreover,
hydrogen removal through methane production alters the whole
of gut fermentation processes, which could potentially affect
colon peristalsis.33 Alternatively, increased abundance could
reflect the fitness of a genus to grow in conditions of slowed-
down intestinal transit. As firmer stool consistencies correspond
with reduced ecosystem water activity, associated fluctuations in
microbial abundances could also result from species-specific
resistance to water stress.
The human colon ecosystem is an open, nutrient-rich and
continuous-flow environment. In order to avoid washout, the
residing bacteria can either reproduce at a sufficiently high
growth rate or attach to or colonise host tissues.35 Hence,
transit time may act as a selective force on gut bacterial growth
rates. Indeed, higher fluctuations in nutrient availability and
microbiota population size induced by decreased colon transit
time would be the text-book selection pressure for fast growing
bacteria, outgrowing their slow growing counterparts whenever
resources are available (r-selection).36 Also enhanced water
activity and the associated increase of nutrient mobility in loose
stools will contribute to the selective force imposed by acceler-
ated transit. Indications for the suggested correlation between
bacterial growth rates and rates of passage come from in vitro
work with continuous flow fermenters37–39—where dilution
rates determine pace of growth of the bacteria cultured—and in
vivo observations of higher faecal bacterial biomass associated
with shorter transit times.40 41 To assess this hypothesis, we esti-
mated each sample’s microbiota growth potential as the average
of the maxGR25 (see methods) of the genera, weighted by their
abundance in the sample (based on de novo OTU as well as
closed reference OTU assignment; online supplementary table
S5). We find that microbiota growth potential is indeed posi-
tively correlated with stool score, and hence colon transit time,
in the RB enterotype (r=0.34, p=0,028; figure 2). However,
this correlation is absent in the P enterotype (figure 2).
Strikingly, the average growth rate of the P enterotype samples
is lower than the one of the RB samples (median microbiota
growth potential 0.38/h vs 0.52/h, respectively, Wilcoxon
p<10−4; online supplementary figure S6). This is largely driven
by the higher abundance of relatively slow-growing Prevotella
spp in these samples (median relative abundance of Prevotella of
0.48671 vs 0.00026 in the P-enterotype and RB-enterotype,
respectively). On one hand, the absence of correlation between
growth rate and colon transit time in the P enterotype could
suggest that species in this enterotype resort to an alternative
strategy to avoid washout, namely a higher degree of adherence
to host tissues. The fact that Prevotella is indeed able to bind
collagen and degrade mucin oligosaccharides support this
hypothesis.42 43 Alternatively, our results could indicate that
stool consistency and hence water activity in Prevotella indivi-
duals are independent of accelerated transit, and mainly reflect
increased faecal water-binding capacity, for example, related to
fibre consumption. Overall, as faeces and library dilution series
have been shown not to affect compositional readouts in 16S
amplicon analyses44—and the results obtained are thus not due
to technical issues arising from the variation in water content—
our results hint to transit time as one of the determining select-
ive forces on microbial life-strategies.
The results of the present study indicate that major alterations
in species richness or community composition could partially be
reflecting variation in stool consistency, hampering the identifi-
cation, and affecting robustness and reproducibility of disease
markers. While constipation and or diarrhoea are often seen as
indicators of a dysbiotic colon microbiota potentially contribut-
ing to disease symptoms, onset or evolvement, stool consistency
or transit time are not always taken into account as confoun-
ders. We illustrate this concern using a recent study by
Scheperjans et al45 evaluating the role of the microbiota in
Parkinson’s disease. The authors detected a lower abundance of
Figure 2 Microbiota growth potential correlates to faster intestinal
transit in the Ruminococcaceae-Bacteroides (RB) enterotype. Microbiota
growth potential over stool consistency (Bristol Stool Scale (BSS)),
which is proposed as a proxy for transit time, in the RB-enterotype
(r=0.34, p=0.028).
Table 1 Genera abundances significantly correlated with stool
consistency
Genus
Total data set RB enterotype P enterotype
r q Value r q Value r q Value
Akkermansia −0.504 0.0722 −0.528 0.0342 −0.078 0.6696
Bacteroides 0.177 0.6134 0.460 0.0718 −0.048 0.7803
Butyricimonas −0.348 0.0722 −0.406 0.0718 −0.264 0.8620
Methanobrevibacter −0.126 0.0722 −0.095 0.0718 −0.134 0.7978
Methanosphaera −0.305 0.0966 −0.307 0.1318 NA NA
Odoribacter −0.094 0.0966 −0.048 0.2232 −0.284 0.8551
Oxalobacter −0.424 0.0722 −0.460 0.0350 −0.051 0.6127
Genera abundances significantly correlated with stool consistency (BSS) (q<0.1) in the
total data set, the RB enterotype, or the P enterotype. Spearman’s rank order
correlation with Benjamini-Hochberg false discovery rate correction.
BSS, Bristol Stool Scale; NA, not assigned; RB, Ruminococcaceae-Bacteroides.
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Prevotellaceae combined with an increased Ruminococcaceae
population in patients compared with healthy controls.
However, as constipation has been reported as an early
symptom of Parkinson’s disease46 and given the overlap
between the microbiome signal observed and our findings of
BSS-associated fluctuations in microbial abundances, there
might be a risk that the microbiota signature proposed is a mere
consequence of stool consistency differences between healthy
and diseased individuals. To their credit, the authors did include
the Wexner constipation score in the study—yet this score is pri-
marily focused on long-term assessment of severe constipation
(ie, extreme BSS 1) and would not compensate for day-to-day
variation in BSS in patients as well as controls.47 Inclusion of
stool consistency records or colon transit time measurements as
a confounder would have allowed better disentangling of signals
exclusively associated to the disease and those associated to
stool consistency.
CONCLUSION
Together, our results demonstrate a profound association
between stool consistency and all major readouts of gut micro-
biota composition. As increased colon transit time has been
linked to enhanced proteolytic fermentation48–50 and associated
production of potentially deleterious metabolites, the observed
negative correlation between BSS-assessed passage rate and
microbiome richness as reported here challenges the currently
dominating view of high richness being directly associated to
host health. Furthermore, we here identify gut microbial com-
positional differences with stool consistency on community
scale and genus level and evaluate a hypothesised biological
mechanism of how transit time might shape the gut microbiota
through selective pressure on microbial life-strategies. Although
longitudinal studies combining stool score records and direct
transit time measurements are necessary to consolidate the
observed correlations and proposed hypotheses, the strength of
the associations between BSS and species richness, enterotypes
and community composition emphasise the crucial importance
of stool consistency assessment and confounder analysis in gut
microbiota research and clinical studies.
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